Abstract
BackgroundHuman adipose stem cells (hASCs) can promote angiogenesis through secretion of proangiogenic factors such as vascular endothelial growth factor (VEGF). In other cell types, it has been shown that induction of VEGF is mediated by both protease activated receptor 2 (PAR2) and hypoxia inducible factor 1(HIF-1). The present study hypothesized that PAR2 stimulation through activation of kinase signaling cascades lead to induction of HIF-1 and secretion of VEGF.Methodology/Principal FindingsImmunohistochemistry revealed the expression of PAR2 receptors on the surface of hASCs. Blocking the PAR2 receptors with a specific antibody prior to trypsin treatment showed these receptors are involved in trypsin-evoked increase in VEGF secretion from hASCs. Blocking with specific kinase inhibitors suggested that that activation of MEK/ERK and PI3-kinase/Akt pathways are involved in trypsin-eveoked induction of VEGF. The effect of the trypsin treatment on the transcription of VEGF peaked at 6 hours after the treatment and was comparable to the activation observed after keeping hASCs for 24 hours at 1% oxygen. In contrast to hypoxia, trypsin alone failed to induce HIF-1 measured with ELISA, while the combination of trypsin and hypoxia had an additive effect on both VEGF transcription and secretion, results which were confirmed by Western blot.ConclusionIn hASCs trypsin and hypoxia induce VEGF expression through separate pathways.
Highlights
The transplantation of human adipose-derived stem cells to induce angiogenesis is increasingly recognised as a therapeutic modality in the treatment of ischemic disease [1,2,3]
To address the hypothesis we examined in Human adipose stem cells (hASCs) the expression and the effect of stimulating and blocking protease activated receptor 2 (PAR2) receptors on vascular endothelial growth factor (VEGF), inhibitors of Rho kinase (ROCK), PI3K, and MEK were applied and phosphorylation of the downstream kinases and VEGF induction was examined
Role of PAR2 in Trypsin-mediated Upregulation of VEGF Initially, we investigated whether PAR2 is expressed by hASCs
Summary
The transplantation of human adipose-derived stem cells (hASCs) to induce angiogenesis is increasingly recognised as a therapeutic modality in the treatment of ischemic disease [1,2,3]. The angiogenic effect induced by hASCs is mainly paracrine, exerted through cytokines, such as the vascular endothelial growth factor (VEGF) [5]. VEGF has been shown to be induced both by activation of protease activated receptor 2 (PAR2) signalling and by the transcription factor hypoxia inducible factor 1 (HIF-1) [9,10,11]. Human adipose stem cells (hASCs) can promote angiogenesis through secretion of proangiogenic factors such as vascular endothelial growth factor (VEGF). It has been shown that induction of VEGF is mediated by both protease activated receptor 2 (PAR2) and hypoxia inducible factor 1(HIF-1). The present study hypothesized that PAR2 stimulation through activation of kinase signaling cascades lead to induction of HIF-1 and secretion of VEGF
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have